Skip to content
Thursday, November 20, 2025
SMS Alerts

  • YouTube
  • Instagram
  • Twitter
  • Telegram
  • Home 🟧
  • Instagram
  • Telegram
  • Text Message Alerts📱
  • Twitter / X
  • YouTube▶️
  • Contact Us

Category: Healthcare

  • Home
  • Red Hot Stocks
  • Healthcare
Community Health Systems (NYSE: $CYH) Soars 18%+ After It Reports Q3 2025 Earnings: Is CYH A Buy?
  • Healthcare
  • Red Hot Stocks

Community Health Systems (NYSE: $CYH) Soars 18%+ After It Reports Q3 2025 Earnings: Is CYH A Buy?

  • Lawrence Bolt
  • October 24, 2025
  • 0

Community Health Systems (NYSE: $CYH) is the largest provider of general hospital healthcare services in the US when it comes to the number of acute […]

AstraZeneca (NASDAQ: $AZN) Releases Q1 Fiscal 2025 Results: Is This Pharma Stock A Great Buy After Its Q1 Results?
  • Drug Manufacturers
  • Healthcare
  • Red Hot Stocks

AstraZeneca (NASDAQ: $AZN) Releases Q1 Fiscal 2025 Results: Is This Pharma Stock A Great Buy After Its Q1 Results?

  • Lawrence Bolt
  • April 29, 2025
  • 0

AstraZeneca (NASDAQ: $AZN) posted its Q1 2025 earnings on April 29. The stock trades at $70.13. Revenue for the quarter rose 10% year-over-year to $13.59 […]

UnitedHealth Group (NYSE: $UNH) Drops 22%+ After Q1 Earnings Miss and 2025 Guidance Cut
  • Healthcare
  • Healthcare Plans
  • Red Hot Stocks

UnitedHealth Group (NYSE: $UNH) Drops 22%+ After Q1 Earnings Miss and 2025 Guidance Cut

  • Lawrence Bolt
  • April 17, 2025
  • 0

UnitedHealth Group (NYSE: $UNH) reported its first-quarter 2025 earnings, but the results and revised guidance disappointed investors. As of 12:47 PM EDT, the stock was […]

Abbott Laboratories (NYSE: $ABT) Releases Q1 Fiscal 2025 Results: Is ABT a Buy Amid Macroeconomic Headwinds?
  • Healthcare
  • Medical Devices
  • Red Hot Stocks

Abbott Laboratories (NYSE: $ABT) Releases Q1 Fiscal 2025 Results: Is ABT a Buy Amid Macroeconomic Headwinds?

  • Lawrence Bolt
  • April 16, 2025
  • 0

Abbott Laboratories (NYSE: $ABT) announced Q1 fiscal 2025 results on Wednesday, April 16th. The healthcare firm posted $1.33 billion in net income. Adjusted earnings reached […]

Johnson & Johnson (NYSE: JNJ) Releases Q1 Fiscal 2025 Results: Is This Dividend Stock Still a Buy Amid Tariff Fears?
  • Drug Manufacturers
  • Healthcare
  • Red Hot Stocks

Johnson & Johnson (NYSE: JNJ) Releases Q1 Fiscal 2025 Results: Is This Dividend Stock Still a Buy Amid Tariff Fears?

  • Lawrence Bolt
  • April 15, 2025
  • 0

Johnson & Johnson (NYSE: $JNJ), a major multinational that produces medical devices and pharmaceuticals, released its first-quarter fiscal 2025 results on Tuesday, April 15, 2025, […]

OKYO Pharma (NASDAQ: OKYO) Reports Positive Stability Data For Urcosimod: Is Now The Time To Buy OKYO? 
  • Biotech
  • Healthcare
  • Red Hot Stocks
  • Sponsored

OKYO Pharma (NASDAQ: OKYO) Reports Positive Stability Data For Urcosimod: Is Now The Time To Buy OKYO? 

  • Lawrence Bolt
  • April 1, 2025
  • 0

OKYO Pharma (NASDAQ: $OKYO), a clinical stage biopharmaceutical company, announced a major stability milestone for its drug candidate urcosimod on Monday, March 31, 2025. Details […]

Posts pagination

1 2 … 12 Next
Subscribe for the Latest News & Breakout Alerts:
*By Clicking 'Subscribe Now', You Hereby Agree That You Had Read, Understand, & Are In Agreement To All Terms & Conditions In Our Disclaimer & Privacy Policy.
Copyright © 2025 | DEXWireNews | PR News Videos | InteractiveApps